New Jersey Assembly Bill AJR201

New Jersey 2024-2025 Regular Session

• Introduced: 10/21/24
• Refer: 10/21/24

Caption

Designates last full week of September of each year as "Frontotemporal Degeneration Awareness Week" in NJ.

Impact

The designation of 'Frontotemporal Dementia Awareness Week' is intended to inform New Jersey residents about the effects of FTD, which is among the most common forms of dementia affecting those under 60. By bringing attention to this condition through public events and initiatives, the resolution seeks to foster greater understanding and potentially improve outcomes for those affected by the disease. Furthermore, it aligns with the goals of the National Plan to Address Alzheimer's Disease, highlighting the importance of research and support for individuals with dementia-related disorders.

Summary

AJR201 is a joint resolution introduced in the New Jersey Legislature which designates the last full week of September as 'Frontotemporal Dementia Awareness Week'. The resolution aims to increase public awareness about Frontotemporal dementia (FTD), a terminal and incurable neurodegenerative disease that significantly impacts communication, personality, behavior, and motor skills. The bill recognizes the challenges faced by individuals with FTD and their families, including long diagnostic delays that average about 3.6 years, and the high cost of care associated with the disease, which is noted to be approximately twice that of Alzheimer's disease.

Contention

While the resolution primarily focuses on raising awareness, it underscores the need for further research and understanding of FTD. It acknowledges the plight of individuals who often suffer from misdiagnosis and the social and emotional challenges that accompany the disease. One notable point of contention within the discussions surrounding this initiative involves the urgent call for more resources and widespread public education on the symptoms of FTD, given its often overlooked nature compared to more recognized forms of dementia. Advocates emphasize that such initiatives could lead to improved diagnosis rates and enhanced support for affected families.